Cynthia Sears, M.D., FIDSA, Bloomberg~Kimmel Professor of Cancer Immunotherapy, was named next Editor-in-Chief of the Journal of Infectious Diseases. Dr. Sears leads the microbiome program at the Bloomberg~Kimmel Institute for Cancer Immunotherapy, studying how the “bugs” we live with contribute to cancer development and impact the immune response to cancer. Read the full announcement from […]
Liver cancer is one of the fastest-growing causes of cancer death in the U.S. and in many other parts of the world, says Mark Yarchoan, co-director of the Liver Cancer Multidisciplinary Clinic. Since the new liver cancer clinic launched a little more than a year ago, they have seen a more than 500% increase in […]
Arnold’s advanced pancreas cancer that had spread to his liver was eliminated with a low-dose, five-drug combination being studied in a clinical trial led by Dung Le. Le is now testing new iterations of the therapy to see if she can help more patients. A new drug cocktail adds immunotherapy and a PARP inhibitor to […]
cpetty7 ⋅ Bloomberg~Kimmel Institute For Cancer Immunotherapy, Dung Le, immunotherapy, Johns Hopkins Kimmel Cancer Center, Karim Boudadi, Lustgarten Foundation, Michael Pishvaian, Nilofer Azad, PARP, precision medicine, Research, Swim Across America, treatment ⋅
In this Cancer Matters podcast, Dr Bill Nelson speaks with Dr Mark Yarchoan about the diagnosis and treatment of liver cancer.
In the latest Cancer Matters podcast, Dr Bill Nelson and Dr Jonathan Powell discuss how T cells activated from the immune system are being used to fight cancer.
Each year, the American Cancer Society publishes data that gives a review of cancer statistics with foundational data that tells us about new cases in the U.S. and details on incidence and survival statistics state by state, overall and by cancer type. The latest report, which made headlines for a historic drop in cancer deaths, […]
Clinton ⋅ Issues & Perspectives, Prevention/Screening American Cancer Society, Bloomberg~Kimmel Institute For Cancer Immunotherapy, Cancer Matters, Combination Therapy, Johns Hopkins Kimmel Cancer Center, lung cancer, precision medicine, Research, Russell Hales, screening, Survivorship, treatment ⋅
Some days, when 37-year-old Kristina Baum laces up her running shoes and starts out on her daily training run, she says she feels like someone is taking a sledgehammer to her lungs. Other days, she feels fantastic. That’s really not too different from how other runners training for a marathon describe the ups and downs […]
In the latest Cancer Matters podcast, Dr Bill Nelson talks with Dr Lei Zheng from the Bloomberg~Kimmel Institute for Cancer Immunotherapy about his research into how the immune system can be used to respond to pancreatic cancer. To listen, click here: http://bit.ly/leizheng
Combinations strategies involving checkpoint immunotherapies were approved as first-line options in two cancer types and showed promise in clinical trials for several hard-to-treat cancers. Important advances were also made with respect to immune-related biomarkers, cellular immunotherapies, and personalized vaccines. Elizabeth Jaffee, M.D., deputy director of the Johns Hopkins Kimmel Cancer Center, is focusing her research […]
Larry Frum ⋅ Issues & Perspectives, Prevention/Screening Bloomberg~Kimmel Institute For Cancer Immunotherapy, Cancer Research Institute, checkpoint immunotherapy, Elizabeth Jaffee, immunotherapy, Johns Hopkins Kimmel Cancer Center, precision medicine, treatment, webinar ⋅
Three Johns Hopkins Kimmel Cancer Center researchers were recognized as the first Bloomberg~Kimmel professors in cancer immunology during a ceremony at Johns Hopkins. The event marked the beginning of the Bloomberg~Kimmel Professorships program, and the three scientists were recognized for their work in precision immunotherapy, the bacterial contributions in the microbiome, and how targeting the […]